Cancer News and Research

Latest Cancer News and Research

Starving breast cancer cells of hedgehog significantly slows tumour growth and spread

Starving breast cancer cells of hedgehog significantly slows tumour growth and spread

Recommendations on new cancer drug review process fall short in several ways: CCAC

Recommendations on new cancer drug review process fall short in several ways: CCAC

Newly diagnosed cancer patients face hurdles in receiving oncologist's appointment

Newly diagnosed cancer patients face hurdles in receiving oncologist's appointment

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

GW researchers demonstrate Mta1 gene's role in survival of schistosomes

GW researchers demonstrate Mta1 gene's role in survival of schistosomes

Researcher to evaluate new approach for treatment of triple-negative breast cancer

Researcher to evaluate new approach for treatment of triple-negative breast cancer

Compassionate release programs for prisoners need to be reformed: Research

Compassionate release programs for prisoners need to be reformed: Research

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

Researchers identify 'epigenetic fingerprints' of healthy volunteers, patients with common diseases

Researchers identify 'epigenetic fingerprints' of healthy volunteers, patients with common diseases

From the legislatures: Calif. Assembly passes rate regulation bill; Wis. lawmakers vote to raise health costs for new firefighters, police

From the legislatures: Calif. Assembly passes rate regulation bill; Wis. lawmakers vote to raise health costs for new firefighters, police

Survival rates of wealthier patients with glioblastoma are longer than poorer patients

Survival rates of wealthier patients with glioblastoma are longer than poorer patients

Five years after cancer treatment, many survivors still suffer symptoms

Five years after cancer treatment, many survivors still suffer symptoms

Peptide vaccine, Interleukin-2 show promise for patients with metastatic melanoma

Peptide vaccine, Interleukin-2 show promise for patients with metastatic melanoma

Additional data supporting utility of PAM50 gene signature for breast cancer to be presented at ASCO 2011

Additional data supporting utility of PAM50 gene signature for breast cancer to be presented at ASCO 2011

Thermography is not a substitute for mammography, warns FDA

Thermography is not a substitute for mammography, warns FDA

Maryland researchers deny link between cell phone radiation and brain cancer

Maryland researchers deny link between cell phone radiation and brain cancer

Enzyme Research journal publishes new peer-reviewed article involving Protandim

Enzyme Research journal publishes new peer-reviewed article involving Protandim

Johns Hopkins researchers solve long-standing mystery of Warburg effect

Johns Hopkins researchers solve long-standing mystery of Warburg effect

SBRT is effective for patients with low-to-intermediate-risk prostate cancer: Researchers

SBRT is effective for patients with low-to-intermediate-risk prostate cancer: Researchers

EntreMed's ENMD-2076 Phase 2 trial data on platinum-resistant ovarian cancer presented at ASCO 2011

EntreMed's ENMD-2076 Phase 2 trial data on platinum-resistant ovarian cancer presented at ASCO 2011

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.